Nitrous Oxide- Suicidal Ideation

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Major Depressive DisorderDepressionMood DisordersSuicidal Ideation
Interventions
DRUG

Nitrous Oxide

Nitrous oxide, an odorless, colorless gas typically used as an induction agent for general anesthesia or for dental sedation, is a known N-methyl-D-aspartate (NMDA) antagonist. It will be given at 50% nitrous oxide/50% oxygen in this study.

DRUG

Placebo gas

Placebo gas given at 50% nitrogen \[inert\]/50% oxygen.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

American Foundation for Suicide Prevention

OTHER

lead

Washington University School of Medicine

OTHER